First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3)

NCT03011528 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Ewing Sarcoma Family of Tumors

Interventions

DRUG: VDC-IE x2
DRUG: VDC-IE
DRUG: TEMIRI
DRUG: Consolidation BuMel
DRUG: Maintenance
PROCEDURE: Local treatment by surgery
RADIATION: Local treatment by radiotherapy

Sponsor

Institut Curie

Collaborators

[object Object]